CSF2 and autoimmune pulmonary alveolar proteinosis: Very recently, the results of a meta-analysis of observational studies [35] suggest a cumulative response rate of 59% with GM-CSF therapy in autoimmune PAP, with a trend towards better response via the inhaled route compared to the subcutaneous route.